Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYTOTOXIC LYMPHOCYTES-T' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2215 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Molinier-Frenkel, V; Lengagne, R; Gaden, F; Hong, SS; Choppin, J; Gahery-Segard, H; Boulanger, P; Guillet, JG
      Adenovirus hexon protein is a potent adjuvant for activation of a cellularimmune response

      JOURNAL OF VIROLOGY
    2. Pal, R; Venzon, D; Letvin, NL; Santra, S; Montefiori, DC; Miller, NR; Tryniszewska, E; Lewis, MG; VanCott, TC; Hirsch, V; Woodward, R; Gibson, A; Grace, M; Dobratz, E; Markham, PD; Hel, Z; Nacsa, J; Klein, M; Tartaglia, J; Franchini, G
      ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency

      JOURNAL OF VIROLOGY
    3. Maeurer, MJ; Necker, A; Salter, RD; Castelli, C; Hohn, H; Karbach, J; Freitag, K; Neukirch, C; Knuth, A; Jager, E
      Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue

      INTERNATIONAL JOURNAL OF CANCER
    4. Cross, GG; Jennings, HJ; Whitfield, DM; Penney, CL; Zacharie, B; Gagnon, L
      Immunostimulant oxidized beta-glucan conjugates

      INTERNATIONAL IMMUNOPHARMACOLOGY
    5. Kim, KD; Choi, SC; Kim, A; Choe, YK; Choe, IS; Lim, JS
      Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction

      INTERNATIONAL IMMUNOPHARMACOLOGY
    6. Slifka, MK; Whitton, JL
      Functional avidity maturation of CD8(+)T cells without selection of higheraffinity TCR

      NATURE IMMUNOLOGY
    7. Kalergis, AM; Boucheron, N; Doucey, MA; Palmieri, E; Goyarts, EC; Vegh, Z; Luescher, IF; Nathenson, SG
      Efficient cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex

      NATURE IMMUNOLOGY
    8. Stanislawski, T; Voss, RH; Lotz, C; Sadovnikova, E; Willemsen, RA; Kuball, J; Ruppert, T; Bolhuis, RLH; Melief, CJ; Huber, C; Stauss, HJ; Theobald, M
      Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

      NATURE IMMUNOLOGY
    9. Alyea, EP; Anderson, KC
      Allotransplantation for multiple myeloma

      CANCER JOURNAL
    10. Syme, RM; Bryan, TL; Gluck, S
      Dendritic cell-based therapy: A review focusing on antigenic selection

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    11. Syme, RM; Duggan, P; Stewart, D; Gluck, S
      Generation of dendritic cells ex vivo: Differences in steady state versus mobilized blood from patients with breast cancer, with lymphoma, and from normal donors

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    12. Dan, QH; Sanchez, R; Delgado, C; Wepsic, HT; Morgan, K; Chen, YJ; Jeffes, EWB; Lowell, CA; Morgan, TR; Jadus, MR
      Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-Cell immunity against the parental tumor

      MOLECULAR THERAPY
    13. Zhang, Y; Chirmule, N; Gao, GP; Qian, R; Croyle, M; Joshi, B; Tazelaar, J; Wilson, JM
      Acute cytokine response to systemic adenoviral vectors in mice is mediatedby dendritic cells and macrophages

      MOLECULAR THERAPY
    14. Sung, RS; Qin, LH; Bromberg, JS
      TNF alpha and IFN gamma induced by innate anti-adenoviral immune responsesinhibit adenovirus-mediated transgene expression

      MOLECULAR THERAPY
    15. Kuzmin, AI; Galenko, O; Eisensmith, RC
      An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors

      MOLECULAR THERAPY
    16. Mocellin, S; Fetsch, T; Abati, T; Phan, GQ; Wang, J; Provenzano, M; Stroncek, D; Rosenberg, SA; Marincola, FM
      Laser scanning cytometry evaluation of MART-1, gp100, and HLA-A2 expression in melanoma metastases

      JOURNAL OF IMMUNOTHERAPY
    17. Musk, P; Szmania, S; Galloway, A; Johnson, K; Scott, A; Guttman, S; Bridges, K; Bruorton, M; Gatlin, J; Garcia, JV; Lamb, L; Chiang, KY; Spencer, T; Henslee-Downey, J; van Rhee, F
      In vitro generation of Epstein-Barr virus-specific cytotoxic T cells in patients receiving haplo-identical allogeneic stem cell transplantation

      JOURNAL OF IMMUNOTHERAPY
    18. Maruyama, K; Akiyama, Y; Nara-Ashizawa, N; Hojo, T; Cheng, JY; Mizuguchi, H; Hayakawa, T; Yamaguchi, K
      Adenovirus-mediated MUC1 gene transduction into human blood-derived dendritic cells

      JOURNAL OF IMMUNOTHERAPY
    19. Riley, JP; Rosenberg, SA; Parkhurst, MR
      Identification of a new shared HLA-A2.1 restricted epitope from the melanoma antigen tyrosinase

      JOURNAL OF IMMUNOTHERAPY
    20. Cho, HI; Han, H; Kim, CC; Kim, TG
      Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro

      JOURNAL OF IMMUNOTHERAPY
    21. Sykes, M
      Graft-versus-host alloresponses to treat nonlymphohematopoietic tumors: Isthere a solid approach?

      JOURNAL OF IMMUNOTHERAPY
    22. Hoffmann, TK; Meidenbauer, N; Muller-Berghaus, J; Storkus, WJ; Whiteside, TL
      Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells

      JOURNAL OF IMMUNOTHERAPY
    23. Bownds, S; Tong-On, P; Rosenberg, SA; Parkhurst, M
      Induction of tumor-reactive cytotoxic T-lymphocytes using a peptide from NY-ESO-1 modified at the carboxy-terminus to enhance HLA-A2.1 binding affinity and stability in solution

      JOURNAL OF IMMUNOTHERAPY
    24. Man, S; Fiander, A
      Immunology of human papillomavirus infection in lower genital tract neoplasia

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    25. Stern, PL; Faulkner, R; Veranes, EC; Davidson, EJ
      The role of human papillomavirus vaccines in cervical neoplasia

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    26. Torelli, GF; Orsini, E; Guarini, A; Kell, J; Foa, R
      Developmental approaches in immunological control of acute myelogenous leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    27. Anthony, DD; Post, AB; Valdez, H; Peterson, DL; Murphy, M; Heeger, PS
      ELISPOT analysis of hepatitis C virus protein-specific IFN-gamma-producingperipheral blood lymphocytes in infected humans with and without cirrhosis

      CLINICAL IMMUNOLOGY
    28. Tanaka, Y; Koido, S; Chen, DS; Gendler, SJ; Kufe, D; Gong, JL
      Vaccination with allogeneic dendritic induces antitumor immunity in cells fused to carcinoma cells MUC1 transgenic mice

      CLINICAL IMMUNOLOGY
    29. Mealey, RH; Fraser, DG; Oaks, JL; Cantor, GH; McGuire, TC
      Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: Lessons for control of lentiviruses

      CLINICAL IMMUNOLOGY
    30. Khanna, R; Tellam, J; Duraiswamy, J; Cooper, L
      Immunotherapeutic strategies for EBV-associated malignancies

      TRENDS IN MOLECULAR MEDICINE
    31. Zhu, DL; Rice, J; Savelyeva, N; Stevenson, FK
      DNA fusion vaccines against B-cell tumors

      TRENDS IN MOLECULAR MEDICINE
    32. Prud'homme, GJ; Lawson, BR; Chang, YG; Theofilopoulos, AN
      Immunotherapeutic gene transfer into muscle

      TRENDS IN IMMUNOLOGY
    33. Campbell, JDM; Cook, G; Holyoake, TL
      Evolution of bone marrow transplantation - the original immunotherapy

      TRENDS IN IMMUNOLOGY
    34. Jenne, L; Schuler, G; Steinkasserer, A
      Viral vectors for dendritic cell-based immunotherapy

      TRENDS IN IMMUNOLOGY
    35. Overwijk, WW; Restifo, NP
      Creating therapeutic cancer vaccines: notes from the battlefield

      TRENDS IN IMMUNOLOGY
    36. Rousseau, RF; Bollard, CM; Heslop, HE
      Gene therapy for paediatric leukaemia

      EXPERT OPINION ON BIOLOGICAL THERAPY
    37. Morse, MA; Clay, TM; Hobeika, AC; Mosca, PJ; Lyerly, HK
      Surrogate markers of response to cancer immunotherapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    38. Eo, SK; Pack, C; Kumaraguru, U; Rouse, BT
      Optimisation of DNA vaccines for the prophylaxis and modulation of herpes simplex virus infections

      EXPERT OPINION ON BIOLOGICAL THERAPY
    39. Holmes, EC
      On the origin and evolution of the human immunodeficiency virus (HIV)

      BIOLOGICAL REVIEWS
    40. Kudo, T; Egawa, H; Kuzushima, K; Kimura, H; Morishima, T; Ichiyama, S
      Diagnostic testing in Epstein-Barr virus infection

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    41. Schirmbeck, R; Reimann, J
      Revealing the potential of DNA-based vaccination: Lessons learned from thehepatitis B virus surface antigen

      BIOLOGICAL CHEMISTRY
    42. Singh-Jasuja, H; Hilf, N; Arnold-Schild, D; Schild, H
      The role of heat shock proteins and their receptors in the activation of the immune system

      BIOLOGICAL CHEMISTRY
    43. O'Hagan, DT; MacKichan, ML; Singh, M
      Recent developments in adjuvants for vaccines against infectious diseases

      BIOMOLECULAR ENGINEERING
    44. Wainberg, MA; White, AJ
      Current insights into reverse transcriptase inhibitor-associated resistance

      ANTIVIRAL THERAPY
    45. Mallal, S
      Resistance and other factors involved in therapy failure

      ANTIVIRAL THERAPY
    46. Spack, EG; Sorgi, FL
      Developing non-viral DNA delivery systems for cancer and infectious disease

      DRUG DISCOVERY TODAY
    47. Multhoff, G; Pfister, K; Gehrmann, M; Hantschel, M; Gross, C; Hafner, M; Hiddemann, W
      A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity

      CELL STRESS & CHAPERONES
    48. Du Pasquier, RA; Clark, KW; Smith, PS; Joseph, JT; Mazullo, JM; De Girolami, U; Letvin, NL; Koralnik, IJ
      JCV-specific cellular immune response correlates with a favorable clinicaloutcome in HIV-infected individuals with progressive multifocal leukoencephalopathy

      JOURNAL OF NEUROVIROLOGY
    49. Nencioni, A; Brossart, P
      New perspectives in dendritic cell-based cancer immunotherapy

      BIODRUGS
    50. Matzku, S; Zoller, M
      Specific immunotherapy of cancer in elderly patients

      DRUGS & AGING
    51. Walter, E; Thiele, L; Merkle, HP
      Gene delivery systems to phagocytic antigen-presenting cells

      STP PHARMA SCIENCES
    52. Sarukhan, A; Soudais, C; Danos, O; Jooss, K
      F;actors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors

      JOURNAL OF GENE MEDICINE
    53. Poloso, N; Nagarajan, S; Bumgarner, GW; Zampell, JC; Selvaraj, P
      Designer cancer vaccines made easy: Protein transfer of immunostimulatory molecules for use in therapeutic tumor vaccines

      FRONTIERS IN BIOSCIENCE
    54. Apostolopoulos, V; McKenzie, IFC; Wilson, IA
      Getting into the groove: Unusual features of peptide binding to MHC class I molecules and implications in vaccine design

      FRONTIERS IN BIOSCIENCE
    55. Greidinger, EL
      Apoptosis in lupus pathogenesis

      FRONTIERS IN BIOSCIENCE
    56. Djavani, M; Yin, C; Lukashevich, IS; Rodas, J; Rai, SK; Salvato, MS
      Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus

      JOURNAL OF HUMAN VIROLOGY
    57. Pei, J; Akatsuka, Y; Anasetti, C; Lin, MT; Petersdorf, EW; Hansen, JA; Martin, PJ
      Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: Analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    58. Barker, JN; Martin, PL; Coad, JE; DeFor, T; Trigg, ME; Kurtzberg, J; Weisdorf, DJ; Wagner, JE
      Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    59. Shimoni, A; Gajewski, J; Donato, M; Martin, T; O'Brien, S; Talpaz, M; Cohen, A; Korbling, M; Champlin, R; Giralt, S
      Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    60. Fabre, JW
      The allogeneic response and tumor immunity

      NATURE MEDICINE
    61. Buseyne, F; Le Gall, S; Boccaccio, C; Abastado, JP; Lifson, JD; Arthur, LO; Riviere, Y; Heard, JM; Schwartz, O
      MHC-I-restricted presentation of HIV-1 virion antigens without viral replication

      NATURE MEDICINE
    62. Belyakov, IM; Hel, Z; Kelsall, B; Kuznetsov, VA; Ahlers, JD; Nacsa, J; Watkins, DI; Allen, TM; Sette, A; Altman, J; Woodward, R; Markham, PD; Clements, JD; Franchini, G; Strober, W; Berzofsky, JA
      Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques

      NATURE MEDICINE
    63. Gorschluter, M; Ziske, C; Glasmacher, A; Schmidt-Wolf, IGH
      Current clinical and laboratory strategies to augment the efficacy of immunotherapy in multiple myeloma

      CLINICAL CANCER RESEARCH
    64. Christ, O; Matzku, S; Burger, C; Zoller, M
      Interleukin 2-antibody and tumor necrosis factor-antibody fusion proteins induce different antitumor immune responses in vivo

      CLINICAL CANCER RESEARCH
    65. Rescigno, M; Valzasina, B; Bonasio, R; Urbano, M; Ricciardi-Castagnoli, P
      Dendritic cells, loaded with recombinant bacteria expressing tumor antigens, induce a protective tumor-specific response

      CLINICAL CANCER RESEARCH
    66. Yamshchikov, G; Thompson, L; Ross, WG; Galavotti, H; Aquila, W; Deacon, D; Caldwell, J; Patterson, JW; Hunt, DF; Slingluff, CL
      Analysis of a natural immune response against tumor antigens in a melanomasurvivor: Lessons applicable to clinical trial evaluations

      CLINICAL CANCER RESEARCH
    67. Demaria, S; Volm, MD; Shapiro, RL; Yee, HT; Oratz, R; Formenti, SC; Muggia, F; Symmans, WF
      Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy

      CLINICAL CANCER RESEARCH
    68. Xu, XN; Purbhoo, MA; Chen, N; Mongkolsapaya, J; Cox, JH; Meier, UC; Tafuro, S; Dunbar, PR; Sewell, AK; Hourigan, CS; Appay, V; Cerundolo, V; Burrows, SR; McMichael, AJ; Screaton, GR
      A novel approach to antigen-specific deletion of CTL with minimal cellularactivation using alpha 3 domain mutants of MHC class I/peptide complex

      IMMUNITY
    69. Scott, M; Nakagawa, M; Moscicki, AB
      Cell-mediated immune response to human papillomavirus infection

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    70. Barry, WH
      Cellular and molecular basis of inflammatory myocardial disease

      JOURNAL OF NUCLEAR CARDIOLOGY
    71. Sastry, KJ; Nehete, PN; Savary, CA
      Impairment of antigen-specific cellular immune responses under simulated microgravity conditions

      IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
    72. Peggs, KS; Mackinnon, S
      Cellular therapy: donor lymphocyte infusion

      CURRENT OPINION IN HEMATOLOGY
    73. Sereti, I; Lane, HC
      Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies

      CLINICAL INFECTIOUS DISEASES
    74. Cohen, DE; Walker, BD
      Human immunodeficieny virus pathogenesis and prospects for immune control in patients with established infection

      CLINICAL INFECTIOUS DISEASES
    75. Grimm, KM; Trigona, WL; Heidecker, GJ; Joyce, JG; Fu, TM; Shiver, JW; Keller, PM; Cook, JC
      An enhanced and scalable process for the purification of SIV gag-specific MHC tetramer

      PROTEIN EXPRESSION AND PURIFICATION
    76. Pai, S; Khanna, R
      Role of LMP1 in immune control of EBV infection

      SEMINARS IN CANCER BIOLOGY
    77. Cano, A; Fragoso, G; Gevorkian, G; Terrazas, LI; Petrossian, P; Govezensky, T; Sciutto, E; Manoutcharian, K
      Intraspleen DNA inoculation elicits protective cellular immune responses

      DNA AND CELL BIOLOGY
    78. Kavanagh, DG; Hill, AB
      Evasion of cytotoxic T lymphocytes by murine cytomegalovirus

      SEMINARS IN IMMUNOLOGY
    79. Piguet, V; Trono, D
      Living in oblivion: HIV immune evasion

      SEMINARS IN IMMUNOLOGY
    80. Xin, KQ; Urabe, M; Yang, J; Nomiyama, K; Mizukami, H; Hamajima, K; Nomiyama, H; Saito, T; Imai, M; Monahan, J; Okuda, K; Ozawa, K; Okuda, K
      A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus

      HUMAN GENE THERAPY
    81. Nishimura, N; Nishioka, Y; Shinohara, T; Sone, S
      Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 gene transduction into human monocyte-derived dendritic cells

      HUMAN GENE THERAPY
    82. Willis, RA; Bowers, WJ; Turner, MJ; Fisher, TL; Abdul-Alim, CS; Howard, DF; Federoff, HJ; Lord, EM; Frelinger, JG
      Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice

      HUMAN GENE THERAPY
    83. Clark, RE; Christmas, SE
      BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia

      LEUKEMIA & LYMPHOMA
    84. Yasukawa, M
      Immunotherapy for leukemia targeting the Wilms' tumor gene

      LEUKEMIA & LYMPHOMA
    85. Sherrill, J; Schock, T; Dunn, JL; St Aubin, DJ; Burnley, VV; Poet, SE
      Humoral immune responses of black-footed penguins (Spheniscus demersus) after DNA-mediated immunization with a beta-galactosidase reporter gene

      JOURNAL OF ZOO AND WILDLIFE MEDICINE
    86. McLaughlin, PMJ; Kroesen, BJ; Harmsen, MC; de Leij, LFMH
      Cancer immunotherapy: insights from transgenic animal models

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    87. Disis, ML; Knutson, KL; McNeel, DG; Davis, D; Schiffman, K
      Clinical translation of peptide-based vaccine trials: The HER-2/neu model

      CRITICAL REVIEWS IN IMMUNOLOGY
    88. Yutani, S; Shichijo, S; Inoue, Y; Kawagoe, N; Okuda, K; Kurohiji, T; Tanaka, M; Sata, M; Itoh, K
      Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas

      ONCOLOGY REPORTS
    89. Gross, T; Wagner, A; Ugurel, S; Tilgen, W; Reinhold, U
      Identification of TIA-1+and granzyme B plus cytotoxic T cells in lichen sclerosus et atrophicus

      DERMATOLOGY
    90. Higaki, Y; Yamada, O; Okamura, T; Mizoguchi, H; Kawashima, M
      Granzyme-B-containing lymphocyte involvement in epidermal injury in graft-versus-host disease

      DERMATOLOGY
    91. Zhuang, L; You, J; Tang, BZ; Ding, SY; Yan, KH; Peng, D; Zhang, YM; Zhang, L
      Preliminary results of Thymosin-a1 versus interferon-alpha treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B

      WORLD JOURNAL OF GASTROENTEROLOGY
    92. You, J; Zhuang, L; Tang, BZ; Yang, WB; Ding, SY; Li, W; Wu, RX; Zhang, HL; Zhang, YM; Yan, SM; Zhang, L
      A randomized controlled clinical trial on the treatment of Thymosin-a1 versus interferon-alpha in patients with hepatitis B

      WORLD JOURNAL OF GASTROENTEROLOGY
    93. Arora, A; Seth, P
      Immunization with HIV-1 subtype B gp160-DNA induces specific as well as cross reactive immune responses in mice

      INDIAN JOURNAL OF MEDICAL RESEARCH
    94. Hsu, KF; Hung, CF; Cheng, WF; He, L; Slater, LA; Ling, M; Wu, TC
      Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen

      GENE THERAPY
    95. Payette, PJ; Weeratna, RD; McCluskie, MJ; Davis, HL
      Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms

      GENE THERAPY
    96. Evans, JT; Cravens, P; Gatlin, J; Kelly, PF; Lipsky, PE; Garcia, JV
      Pre-clinical evaluation of an in vitro selection protocol for the enrichment of transduced CD34(+) cell-derived human dendritic cells

      GENE THERAPY
    97. Parker, SE; Monteith, D; Horton, H; Hof, R; Hernandez, P; Vilalta, A; Hartikka, J; Hobart, P; Bentley, CE; Chang, A; Hedstrom, R; Rogers, WO; Kumar, S; Hoffman, SL; Norman, JA
      Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine

      GENE THERAPY
    98. Muller, V; Maree, AFM; De Boer, RJ
      Small variations in multiple parameters account for wide variations in HIV-1 set-points: a novel modelling approach

      PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    99. Simpson, E; Scott, D; James, E; Lombardi, G; Cwynarski, K; Dazzi, F; Millrain, M; Dyson, PJ
      Minor H antigens: genes and peptides

      EUROPEAN JOURNAL OF IMMUNOGENETICS
    100. Lucas, M; Karrer, U; Lucas, A; Klenerman, P
      Viral escape mechanisms - escapology taught by viruses

      INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 06:56:12